Search Results
The default setting for search results displays All Content. If you prefer to see recent content only, please adjust the date filter.
Filter your results:
Types
Topics
7 Results Found
340B Benefits Patients and Communities: Examples from the Frontlines
The 340B Drug Pricing Program helps ensure access to care for patients and communities most in need. A bipartisan effort by Congress in 1992 designed the program to protect hospitals from rising drug costs — a dynamic that continues to present major challenges today.
Valleywise Health | Arizona
Valleywise Health, with its 340B Program savings, reinvests back into programs that directly benefit patients and the larger community, providing access to high-quality care for all.
Monument Health | South Dakota
Monument Health is the largest health care provider in western South Dakota. It is an integral part of the local community, providing a wide array of vital services including behavioral health, oncology and dialysis care.
University of Louisville Health | Kentucky
University of Louisville (UofL) Health is a fully integrated regional academic health system with nine hospitals, a cancer center, an eye institute and nearly 200 clinics serving communities across Kentucky and Southern Indiana.
Baxter Health | Arkansas
Since Baxter General Hospital was founded in 1963, it has served as a critical lifeline for residents in 11 counties across north-central Arkansas (AR) and south-central Missouri (MO).
340B Arrangements with Community and Specialty Pharmacies Improve Access to Care for Underserved Patients
HRSA, which oversees the 340B program, has recognized the need for hospitals to partner with community and specialty pharmacies. Despite the demonstrated benefits to patients, these arrangements have been criticized by drug companies.
Survey Brief: Drug Companies Reduce Patients’ Access to Care by Limiting 340B Community Pharmacies
Background
In 1992, Congress created the